AIDS - Related Kaposi's Sarcoma – Pipeline Review, H2 2012

Published by: Global Markets Direct

Published: Jul. 31, 2012 - 51 Pages


Table of Contents

Introduction
Global Markets Direct Report Coverage
AIDS - Related Kaposi's Sarcoma Overview
Therapeutics Development
An Overview of Pipeline Products for AIDS - Related Kaposi's Sarcoma
AIDS - Related Kaposi's Sarcoma Therapeutics under Development by Companies
AIDS - Related Kaposi's Sarcoma Therapeutics under Investigation by Universities/Institutes
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
AIDS - Related Kaposi's Sarcoma Therapeutics – Products under Development by Companies
AIDS - Related Kaposi's Sarcoma Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in AIDS - Related Kaposi's Sarcoma Therapeutics Development
Aphios Corporation
Azaya Therapeutics, Inc.
PTC Therapeutics, Inc.
Arisyn Therapeutics Inc.
AIDS - Related Kaposi's Sarcoma – Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Dermos - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PTC299 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ATI 0607 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rapamycin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bevacizumab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Gleevec - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SU5416 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Bortezomib - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lenalidomide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Halofuginone Hydrobromide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Interferon beta-1b + Zidovudine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Lenalidomide - Drug Profile
Product Description
Mechanism of Action
R&D Progress
HAART + Bevacizumab - Drug Profile
Product Description
Mechanism of Action
R&D Progress
ATI-0918 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
AIDS - Related Kaposi's Sarcoma Therapeutics – Drug Profile Updates
AIDS - Related Kaposi's Sarcoma Therapeutics - Dormant Products
AIDS - Related Kaposi's Sarcoma – Product Development Milestones
Featured News & Press Releases
Aug 05, 1997: Taxol Approved for Kaposi's Sarcoma
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products Under Development for AIDS - Related Kaposi's Sarcoma, H2 2012
Products under Development for AIDS - Related Kaposi's Sarcoma – Comparative Analysis, H2 2012
Number of Products under Development by Companies, H2 2012
Number of Products under Investigation by Universities/Institutes, H2 2012
Comparative Analysis by Mid Clinical Stage Development, H2 2012
Comparative Analysis by Early Clinical Stage Development, H2 2012
Comparative Analysis by Pre-Clinical Stage Development, H2 2012
Products under Development by Companies, H2 2012
Products under Investigation by Universities/Institutes, H2 2012
Aphios Corporation, H2 2012
Azaya Therapeutics, Inc., H2 2012
PTC Therapeutics, Inc., H2 2012
Arisyn Therapeutics Inc., H2 2012
Assessment by Monotherapy Products, H2 2012
Assessment by Combination Products, H2 2012
Assessment by Stage and Route of Administration, H2 2012
Assessment by Stage and Molecule Type, H2 2012
AIDS - Related Kaposi's Sarcoma Therapeutics – Drug Profile Updates
AIDS - Related Kaposi's Sarcoma Therapeutics – Dormant Products
AIDS - Related Kaposi's Sarcoma Therapeutics – Dormant Products (Contd..1)
AIDS - Related Kaposi's Sarcoma Therapeutics – Dormant Products (Contd..2)
AIDS - Related Kaposi's Sarcoma Therapeutics – Dormant Products (Contd..3)
List of Figures
Number of Products under Development for AIDS - Related Kaposi's Sarcoma, H2 2012
Products under Development for AIDS - Related Kaposi's Sarcoma – Comparative Analysis, H2 2012
Products under Development by Companies, H2 2012
Products under Investigation by Universities/Institutes, H2 2012
Mid Clinical Stage Products, H2 2012
Early Clinical Stage Products, H2 2012
Pre-Clinical Stage Products, H2 2012
Assessment by Monotherapy Products, H2 2012
Assessment by Combination Products, H2 2012
Assessment by Route of Administration, H2 2012
Assessment by Stage and Route of Administration, H2 2012
Assessment by Molecule Type, H2 2012
Assessment by Stage and Molecule Type, H2 2012

Abstract

AIDS - Related Kaposi's Sarcoma – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, 'AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2012', provides an overview of the AIDS - Related Kaposi's Sarcoma therapeutic pipeline. This report provides information on the therapeutic development for AIDS - Related Kaposi's Sarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi's Sarcoma. 'AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • A snapshot of the global therapeutic scenario for AIDS - Related Kaposi's Sarcoma.
  • A review of the AIDS - Related Kaposi's Sarcoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the AIDS - Related Kaposi's Sarcoma pipeline on the basis of route of administration and molecule type.
  • Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.
Reasons to buy
  • Identify and understand important and diverse types of therapeutics under development for AIDS - Related Kaposi's Sarcoma.
  • Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
  • Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
  • Devise corrective measures for pipeline projects by understanding AIDS - Related Kaposi's Sarcoma pipeline depth and focus of AIDS - Related Kaposi's Sarcoma therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


Get full details about this report >>
 
Learn more about this product


Price and delivery options

Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.